ChemicalBook > Product Catalog >API >Antipyretic analgesics >Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) >Iguratimod

Iguratimod

Iguratimod Suppliers list
Company Name: Henan DaKen Chemical CO.,LTD.
Tel: +86-371-55531817
Email: info@dakenchem.com
Products Intro: Product Name:Iguratimod
CAS:123663-49-0
Purity:99% Package:100g,500g,1kg,5kg,10kg
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: 0371-55170693
Email: info@tianfuchem.com
Products Intro: CAS:123663-49-0
Purity:99% Package:500G;1KG;5KG;25KG
Company Name: Jinan Jianfeng Chemical Co., Ltd
Tel: 15562555968
Email: info@pharmachemm.com
Products Intro: Product Name:Iguratimod
CAS:123663-49-0
Purity:99% Package:5KG;1KG
Company Name: Chemwill Asia Co.,Ltd.
Tel: 86-21-51086038
Email: chemwill_asia@126.com;sales@chemwill.com;chemwill@hotmail.com;chemwill@gmail.com
Products Intro: CAS:123663-49-0
Company Name: career henan chemical co
Tel: +86-371-86658258
Email: sales@coreychem.com
Products Intro: Product Name:Iguratimod
CAS:123663-49-0
Purity:99% Package:1kg;2USD

Lastest Price from Iguratimod manufacturers

  • Iguratimod
  • US $2.00 / kg
  • 2019-04-01
  • CAS:123663-49-0
  • Min. Order: 1kg
  • Purity: 99%
  • Supply Ability: 100kg
Iguratimod Basic information
Product Name:Iguratimod
Synonyms:IGURATIMOD;iguratimod( R&D);T 614;N-[7-methanesulfonamido-4-oxo-6-(phenoxy)chromen-3-yl]formamide;3-(Formylamino)-7-(methylsulfonylamino)-6-phenoxy-4H-1-benzopyran-4-one;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]methanesulfonamide;N-(7-(MethylsulfonaMido)-4-oxo-6-phenoxy-4H-chroMen-3-yl)forMaMide;IguratiMod (T 614)
CAS:123663-49-0
MF:C17H14N2O6S
MW:374.37
EINECS:808-127-0
Product Categories:API;Pharmaceutical intermediate;Pharmaceuticals
Mol File:123663-49-0.mol
Iguratimod Structure
Iguratimod Chemical Properties
Melting point 238.0 to 242.0 °C
Safety Information
MSDS Information
Iguratimod Usage And Synthesis
DescriptionIn August 2011, China’s State FDA approved Simcere Pharmaceutical Group’s new drug application for iguratimod (T-614), a disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Preclinical in vivo studies indicated that iguratimod was effective in an established adjuvant-induced arthritis model (ED40=3.6 mg/kg) in rats and also efficacious in a type II collagen-induced arthritis model in DBA/1J mice at 30 mg and 100 mg/kg.
OriginatorToyama (Japan)
UsesIguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.
Brand nameIremod
Iguratimod Preparation Products And Raw materials
Tag:Iguratimod(123663-49-0) Related Product Information
4-Chloro-3-nitroanisole 3,5-Dihydroxy-4-isopropylstilbene Ambroxol Leflunomide Tacrolimus Methotrexate Ethanone, 1-(4-amino-3-hydroxyphenyl)- (9CI) N-(4-ACETYL-PHENYL)-METHANESULFON-AMIDE 1-(4-AMINO-3-METHOXYPHENYL)-1-ETHANONE 3-ACETYLBIPHENYL (2-PHENOXY)METHYLSULFONYLANILINE Iguratimod N,N-Dimethylformamide Dimethoxymethane DIETHOXYMETHANE CHLOANTRANILIPROLE Formamide phenoxybenzamine